-
公开(公告)号:EP3130592B1
公开(公告)日:2019-08-14
申请号:EP15777444.9
申请日:2015-03-30
申请人: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. , Humanwell Healthcare (Group) Co., Ltd.
发明人: DING, Zhaozhong , CHEN, Shuhui , LI, Gang , WANG, Cailin , ZHANG, Zhibo , TU, Ronghua , WANG, Cailin , YUE, Yang , ZHANG, Zhibo , CHEN, Hailiang , SUN, Wenjie , HUANG, Lu
IPC分类号: C07D487/04 , C07D519/00 , A61P35/00 , A61P25/00 , A61P9/10 , A61P29/00 , A61P3/10
-
2.ANALOGUES OF 4H-PYRAZOLO[1,5- ]BENZIMIDAZOLE COMPOUND AS PARP INHIBITORS 审中-公开
标题翻译: ANALOGA EINER 4H-PYRAZOLO [1,5-A]苯并咪唑-VERBINDUNG ALS PARP-HEMMER公开(公告)号:EP3130592A1
公开(公告)日:2017-02-15
申请号:EP15777444.9
申请日:2015-03-30
申请人: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. , Humanwell Healthcare (Group) Co., Ltd. , Medshine Discovery Inc.
发明人: DING, Zhaozhong , CHEN, Shuhui , LI, Gang , WANG, Cailin , ZHANG, Zhibo , TU, Ronghua , WANG, Cailin , YUE, Yang , ZHANG, Zhibo , CHEN, Hailiang , SUN, Wenjie , HUANG, Lu
IPC分类号: C07D487/04 , C07D519/00 , A61P35/00 , A61P25/00 , A61P9/10 , A61P29/00 , A61P3/10
CPC分类号: C07D487/04 , C07D519/00
摘要: Disclosed is a series of analogues of 4H-pyrazolo[1,5-a]benzimidazole compound as PARP inhibitors. In particular, disclosed in the invention is a compound as shown by formula (I) or a pharmaceutically acceptable salt thereof as a PARP inhibitor.
摘要翻译: 公开了一系列4H-吡唑并[1,5-a]苯并咪唑化合物的类似物作为PARP抑制剂。 特别地,本发明中公开的是式(I)所示的化合物或其药学上可接受的盐作为PARP抑制剂。
-
3.
公开(公告)号:EP3357925A1
公开(公告)日:2018-08-08
申请号:EP16850379.5
申请日:2016-09-29
申请人: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. , Humanwell Healthcare (Group) Co., Ltd. , Medshine Discovery Inc.
发明人: WANG, Xuehai , DING, Charles Z. , SHEN, Jie , CHEN, Shuhui , LI, Lie , LI, Gang , XU, Yong , WANG, Cailin , TU, Ronghua , WANG, Jimeng , YUE, Yang , DENG, Biao , CHEN, Hailiang , LIU, Hui , SUN, Wenjie , WANG, Cong , HUANG, Lu , WANG, Zheng , LI, Weidong
IPC分类号: C07D487/04 , C07D401/04 , A61P35/00
CPC分类号: C07D487/04 , C07B2200/13 , C07C57/145 , C07D401/04
摘要: Disclosed in the present invention are a salt type and crystal type of 4H-pyrazolo[1, 5-alpha]benzimidazole compound and the preparation method and intermediate thereof.
-
-